PS
Preetika Suri
About Preetika Suri
Data last updated:
Preetika Suri is a Director at Supriti Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals. Supriti Pharmaceuticals Private Limited reported revenue of ₹59.9 Lakh (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Supriti Pharmaceuticals Private Limited U24239UR2020PTC011868 | Director | 14 Dec 2020 | 2020 | ₹59.9 Lakh (FY 2022) | Active |
Board colleagues of Preetika Suri
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Suri | 09019693 | Supriti Pharmaceuticals Private Limited | Director |
| Nishad Arora | 09019707 | Supriti Pharmaceuticals Private Limited | Director |
| Sunita Jolly | 08994778 | Supriti Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Preetika Suri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Preetika Suri
Preetika Suri currently holds 1 directorship: Supriti Pharmaceuticals Private Limited (Director, since 14 Dec 2020, revenue ₹59.9 Lakh (FY 2022)).
Preetika Suri was first appointed on 14 Dec 2020 as Director at Supriti Pharmaceuticals Private Limited.
The current boards of Preetika Suri's companies include Amit Suri (Supriti Pharmaceuticals Private Limited), Nishad Arora (Supriti Pharmaceuticals Private Limited), Sunita Jolly (Supriti Pharmaceuticals Private Limited).